Sandoz closes acquisition of GSK’s cephalosporin business

By NS Healthcare Staff Writer

11 Oct 21

Sandoz obtains rights to three established brands, including Zinnat, Zinacef and Fortum, which had combined sales of around…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

AstraZeneca to buy remaining stake in Caelum for $500m

By NS Healthcare Staff Writer

30 Sep 21

With the transaction, the British drugmaker will obtain Caelum’s potential fibril-reactive monoclonal antibody (mAb) CAEL-101 for the treatment…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Merck reportedly to acquire Acceleron in potential $11bn deal

By NS Healthcare Staff Writer

30 Sep 21

Merck will obtain Acceleron's medicines for rare diseases, including its pulmonary arterial hypertension (PAH) drug sotatercept

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Novartis buys Arctos Medical to boost optogenetic portfolio

By NS Healthcare Staff Writer

22 Sep 21

Novartis said that the acquisition is in line with its strategy of finding treatments for patients with vision…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

AstraZeneca to invest $360m to build API manufacturing plant in Ireland

By NS Healthcare Staff Writer

22 Sep 21

The new API manufacturing facility for small molecules will be constructed at the Alexion Campus in College Park…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Roche to acquire TIB Molbiol to expand PCR-testing portfolio

By NS Healthcare Staff Writer

13 Sep 21

The acquisition will enable Roche to further expand the portfolio with more than 45 CE-IVD assays and more…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Baxter agrees to acquire medical technology firm Hillrom for $10.5bn

By NS Healthcare Staff Writer

03 Sep 21

The transaction will advance Baxter and Hillrom’s expansion into digital and connected care solutions that enable hospital-level care…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Pfizer to acquire cancer therapeutics firm Trillium in $2.3bn deal

By NS Healthcare Staff Writer

24 Aug 21

The acquisition is expected to benefit Pfizer with Trillium’s next-generation, investigational immuno-therapeutics for haematological malignancies

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Curia to expand manufacturing capacity at Rensselaer facility, US

By NS Healthcare Staff Writer

20 Aug 21

The expansion is said to increase the company’s capability to manufacture complex APIs and generate new jobs at…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Bayer buys precision therapeutics firm Vividion Therapeutics for $2bn

By NS Healthcare Staff Writer

06 Aug 21

With the acquisition, Bayer will obtain full rights to Vividion’s discovery platform that includes chemoproteomic screening technology, an…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates